朗迪Reneed品牌怎么样 申请店铺

我要投票 朗迪Reneed在补钙行业中的票数:317 更新时间:2025-04-05
朗迪Reneed是哪个国家的品牌?「朗迪Reneed」是 北京振东康远制药有限公司 旗下著名品牌。该品牌发源于北京市,由创始人李昆在2003-11-07期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力朗迪Reneed品牌出海!通过在本页面挂载朗迪Reneed品牌的产品链接和联系邮箱,可以提高朗迪Reneed产品曝光!跨境电商爆单神器,目前只要100元/年哦~

朗迪Reneed怎么样

钙营养补充剂品牌,主打维生素矿物质钙补充剂类药物,集研发、生产、销售于一体的集团化现代综合制药企业


北京振东康远制药有限公司始建于2003年10月,是国内较大的具有自主品牌的维生素矿物质钙补充剂类药物生产企业,是一家集研发、生产、销售于一体的集团化现代综合制药公司,是中国补钙药物的佼佼者和先锋。公司产品遍布全国,公司“朗迪”牌碳酸钙D3片(II)和碳酸钙D3颗粒已成为中国钙补充剂类药品市场的主流。公司2015年与上市公司振东集团山西振东制药股份有限公司强强联合,完成重大重组,实现了跨跃式发展。

公司于2009年进入中国钙制剂市场,旗下现有7家直属或控股的制药公司、2家直属药物研发公司及多家医药贸易公司,在30多个城市设立了办事机构,有数千家合作伙伴,累计总投资超过10亿元,全国有数千名员工为康远工作。

公司位于北京市昌平区西部约15公里的北京市昌平区流村工业园内,隶属中关村科技园昌平园。该厂区自2012年开始建造,总投资近亿元,按照新版欧盟GMP标准及中国GMP标准进行规划、设计和建设施工,配有国际前沿的制粒、干燥、混合、压片、包装等片剂、硬胶囊剂、颗粒剂生产线及软胶囊剂生产线,该项目已于2014年通过了BFDA组织的GMP认证,并获得片剂、硬胶囊剂、颗粒剂、软胶囊剂GMP证书。项目年生产能力近百亿片(粒、袋)。该项目的建成使康远制药一跃成为国内维生素矿物质钙补充剂类药物较大生产企业。

公司发展过程中始终以“构建国人健康骨骼”为已任,以“树民族工业品牌,为中国制药争光”为使命,为中国钙制剂的发展做出了较大的贡献,大大改善了亿万国人的生活质量。康远人负有共同的使命,遵循一致的价值观,始终秉承“济世安康、立勋鸿远”宗旨来服务社会、回报社会。目前公司年营业收入达数十亿元,年上缴税金数亿元。随着公司高速发展和对未来中国经济和全球钙制剂市场发展前景充分信心,北京振东康远制药正不断加快创新、运筹帷幄、酝酿百年规划,未来的康远终将成为一家拥有精良技术和设备、管理成熟的世界制药公司。


Beijing Zhendong Kangyuan Pharmaceutical Co., Ltd., a brand of calcium supplements, is a group modern comprehensive pharmaceutical enterprise integrating R & D, production and sales. It was founded in October 2003. It is a large domestic manufacturer of vitamin and mineral calcium supplements with its own brand, integrating R & D, production and sales Group modern comprehensive pharmaceutical company is the leader and pioneer of calcium supplements in China. The company's products are all over the country, and its "landi" brand calcium carbonate D3 tablets (II) and calcium carbonate D3 particles have become the mainstream of China's calcium supplements market. In 2015, the company and the listed company Zhendong Group Shanxi Zhendong Pharmaceutical Co., Ltd. jointly completed major restructuring and achieved a leap forward development. In 2009, the company entered the calcium preparation market in China. At present, it has 7 pharmaceutical companies directly under or controlled by the company, 2 pharmaceutical research and development companies directly under the company and many pharmaceutical trading companies. It has set up offices in more than 30 cities, thousands of partners, with a total investment of more than 1 billion yuan, and thousands of employees working for Kangyuan. The company is located in Liucun Industrial Park, Changping District, Beijing, about 15km away from the west of Changping District, Beijing. The plant has been constructed since 2012, with a total investment of nearly 100 million yuan. It is planned, designed and constructed in accordance with the new version of EU GMP standard and China GMP standard. It is equipped with internationally cutting-edge tablet, hard capsule, granule production line and soft capsule production line. The project has passed the GMP certification organized by bfda in 2014, and has obtained tablet GMP certificate of hard capsule, granule and soft capsule. The annual production capacity of the project is nearly 10 billion pieces (grain and bag). With the completion of the project, Kangyuan pharmaceutical has become a large domestic manufacturer of vitamin, mineral and calcium supplements. In the development process of the company, we always take "building healthy skeleton of Chinese people" as our responsibility, take "building national industrial brand, winning honor for Chinese pharmaceutical" as our mission, and have made great contribution to the development of Chinese calcium preparation, greatly improving the quality of life of hundreds of millions of Chinese people. Kangyuan people have a common mission, follow the same values, and always adhere to the tenet of "helping the world and health, and making contributions to Hongyuan" to serve and repay the society. At present, the company's annual operating revenue is billions of yuan, and the annual tax payment is hundreds of millions of yuan. With the rapid development of the company and full confidence in the future development of China's economy and the global calcium preparation market, Beijing Zhendong Kangyuan Pharmaceutical Co., Ltd. is constantly accelerating innovation, strategizing and brewing a hundred year plan. In the future, Kangyuan will eventually become a world pharmaceutical company with excellent technology and equipment and well managed.

本文链接: https://brand.waitui.com/52bc17e3b.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

机构:欧洲股市料小幅低开,美国关税继续拖累市场

预计欧洲股市今日开盘将小幅走低,此前美国总统特朗普宣布征收全面贸易关税,导致周四股市大幅下挫。据IG,预计欧洲斯托克600指数将低开0.15%;德国DAX指数和英国富时100指数预计将低开0.1%。投资者担心美国关税政策对全球经济的影响,此外,周五的注意力转向美国的就业数据。这将让人们初步了解美国关税政策宣布前的就业市场状况。投资者还在关注任何有关针对美国关税的反制措施的声明。丹麦银行的分析师在一份研究报告中称:“亚洲股市[周五]上午继续走低,欧洲和美国的股指期货也是如此。(新浪财经)

21分钟前

美油跌至2023年5月以来最低水平

WTI原油期货跌至2023年5月以来最低水平,最低报65.2美元/桶,日内跌2.5%。由于美国推出的所谓“对等关税”严重超出市场预期,投资者对全球经济陷入衰退的担忧加剧。主要产油国5月起将增产,石油输出国组织(欧佩克)3日发表声明说,8个欧佩克和非欧佩克产油国决定自今年5月起日均增产41.1万桶。这一增产量远高于市场预期。(财联社)

21分钟前

蔚来推“5年免费换电”+5年0息限时购车政策

36氪获悉, 4月4日,蔚来宣布,即日起至4月30日期间,用户支付定金购买蔚来ET5、ET5T、ES6、EC6、ET7、EC7、ES8车型,可获赠240张免费换电券(换电券5年有效)。新政策可与现有5年0息金融方案,最高10,000元换电车型专享补贴,以及3年NOP+免费使用权(价值13,680元)同享。此外,以旧换新用户还可享受最高15,000元汽车以旧换新补贴,以及各地消费补贴(以各地公布实施细则为准)。

21分钟前

海南修订细则支持大型演唱会等演出,最高奖励300万元

日前,海南省旅文厅修订并印发《海南省关于支持大型演唱会、音乐节及高品质优秀剧目文艺演出实施细则》,明确符合相关奖励标准的大型演唱会、音乐节,将给予最高300万元一次性奖励。该细则自公布之日起施行,有效期至2025年12月31日,奖补申报时间截至2026年2月28日。(新浪财经)

21分钟前

热门中概股美股盘前全线下行 阿里巴巴、拼多多跌逾8%

热门中概股美股盘前全线下行,阿里巴巴、拼多多跌逾8%,京东跌7.7%,百度、贝壳、小鹏等多股跌6%。(财联社)

21分钟前

本页详细列出关于多维尔的品牌信息,含品牌所属公司介绍,多维尔所处行业的品牌地位及优势。
咨询